Iovance Biotherapeutics (IOVA) Institutional Ownership $3.70 +0.16 (+4.52%) Closing price 04:00 PM EasternExtended Trading$3.68 -0.02 (-0.43%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Iovance Biotherapeutics (NASDAQ:IOVA)CurrentInstitutional OwnershipPercentage77.03%Number ofInstitutional Buyers(last 12 months)148TotalInstitutional Inflows(last 12 months)$132.78MNumber ofInstitutional Sellers(last 12 months)65TotalInstitutional Outflows(last 12 months)$78.26M Get IOVA Insider Trade Alerts Want to know when executives and insiders are buying or selling Iovance Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data IOVA Institutional Buying and Selling by Quarter Iovance Biotherapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE8,490,119$29.80M0.0%-40.5%1.901% 5/19/2026 Janus Henderson Group PLC141,672$498K0.0%+55.1%0.032% 5/19/2026 Arkadios Wealth Advisors20,262$71K0.0%N/A0.005% 5/18/2026 Royal Bank of Canada625,035$2.19M0.0%+2.7%0.140% 5/16/2026 The Manufacturers Life Insurance Company 365,471$1.28M0.0%+57.9%0.082% 5/15/2026 Corsair Capital Management L.P.350,000$1.23M0.2%+16.7%0.078% 5/15/2026 Rice Hall James & Associates LLC1,514,907$5.32M0.3%+6.3%0.339% 5/14/2026 Knott David M Jr1,600,000$5.62M3.3%N/A0.358% 5/14/2026 Sei Investments Co.122,180$429K0.0%+15.7%0.027% 5/13/2026 Cetera Investment Advisers31,094$109K0.0%-56.0%0.007% Get the Latest News and Ratings for IOVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/8/2026 PNC Financial Services Group Inc.25,052$88K0.0%-50.7%0.006% 5/7/2026 Dimensional Fund Advisors LP2,645,702$9.28M0.0%+71.9%0.593% 5/7/2026 KBC Group NV9,586$34K0.0%N/A0.002% 5/6/2026 Annis Gardner Whiting Capital Advisors LLC100,400$352K0.1%N/A0.022% 5/6/2026 Ceera Investments LLC12,465$44K0.0%N/A0.003% 5/5/2026 Sanctuary Advisors LLC10,968$38K0.0%N/A0.002% 5/4/2026 Chicago Partners Investment Group LLC52,653$186K0.0%+29.7%0.012% 5/1/2026 Fifth Third Bancorp11,230$39K0.0%N/A0.003% 5/1/2026 Sequoia Financial Advisors LLC31,266$110K0.0%N/A0.007% 4/30/2026 Hsbc Holdings PLC27,484$98K0.0%-84.8%0.006% 4/30/2026 Kestra Advisory Services LLC34,891$122K0.0%+242.4%0.008% 4/30/2026 Granite Investment Partners LLC18,843$66K0.0%+77.1%0.005% 4/29/2026 R Squared Ltd26,883$94K0.1%-22.2%0.007% 4/28/2026 Abel Hall LLC24,406$86K0.0%N/A0.006% 4/27/2026 Leonteq Securities AG160,000$562K0.0%-17.9%0.039% 4/22/2026 Pictet Asset Management Holding SA43,048$151K0.0%+58.7%0.010% 4/22/2026 Sterling Capital Management LLC11,177$39K0.0%-36.9%0.003% 4/21/2026 Sugar Maple Asset Management LLC120,000$421K0.3%+9.1%0.029% 4/21/2026 Penbrook Management LLC42,445$149K0.1%+25.0%0.010% 4/17/2026 Krilogy Financial LLC15,376$58K0.0%N/A0.004% 4/16/2026 SG Americas Securities LLC167,878$589K0.0%+203.1%0.041% 3/20/2026 Hsbc Holdings PLC180,541$497K0.0%+651.5%0.044% 3/17/2026 Rockefeller Capital Management L.P.50,726$138K0.0%+187.6%0.012% 3/3/2026 Caitong International Asset Management Co. Ltd47,277$129K0.0%+658.9%0.011% 2/19/2026 Invesco Ltd.1,251,665$3.42M0.0%+32.4%0.315% 2/18/2026 XTX Topco Ltd522,934$1.43M0.0%+148.4%0.132% 2/18/2026 VARCOV Co.92,806$253K0.1%N/A0.023% 2/18/2026 Virtus Investment Advisers LLC310,641$848K0.2%+61.5%0.078% 2/18/2026 Tudor Investment Corp ET AL179,494$490K0.0%+47.4%0.045% 2/18/2026 Quadrature Capital Ltd318,703$870K0.0%N/A0.080% $30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.Watch the free video to get the ticker today.2/18/2026 One68 Global Capital LLC20,000$55K0.6%N/A0.005% 2/18/2026 Perceptive Advisors LLC152,714$417K0.0%N/A0.038% 2/18/2026 Intrepid Family Office LLC30,000$82K0.1%-25.0%0.008% 2/18/2026 Invenomic Capital Management LP11,959,505$32.65M1.5%+13.5%3.013% 2/18/2026 Engineers Gate Manager LP194,691$532K0.0%N/A0.049% 2/18/2026 First Manhattan CO. LLC.28,998$79K0.0%-46.6%0.007% 2/18/2026 Balyasny Asset Management L.P.68,038$186K0.0%-24.9%0.017% 2/17/2026 AQR Capital Management LLC110,591$302K0.0%+9.1%0.028% 2/17/2026 Cetera Investment Advisers70,674$193K0.0%-7.0%0.018% 2/17/2026 EFG International AG168,000$459K0.0%N/A0.042% 2/17/2026 Jain Global LLC312,096$852K0.0%N/A0.079% 2/17/2026 Jump Financial LLC22,062$60K0.0%N/A0.006% 2/17/2026 Price T Rowe Associates Inc. MD1,191,828$3.26M0.0%-42.1%0.300% 2/17/2026 Osaic Holdings Inc.102,155$279K0.0%-4.0%0.026% 2/17/2026 Quantitative Investment Management LLC138,583$378K0.0%N/A0.035% 2/17/2026 Corsair Capital Management L.P.300,000$819K0.1%N/A0.076% 2/17/2026 California State Teachers Retirement System295,997$808K0.0%+18.0%0.075% 2/17/2026 Russell Investments Group Ltd.198,043$541K0.0%+195.7%0.050% 2/17/2026 State of Wisconsin Investment Board109,997$300K0.0%-4.4%0.028% 2/17/2026 Captrust Financial Advisors46,812$128K0.0%+13.5%0.012% 2/17/2026 ExodusPoint Capital Management LP281,477$768K0.0%+568.2%0.071% 2/17/2026 Royal Bank of Canada608,459$1.66M0.0%-60.9%0.153% 2/17/2026 Beacon Financial Advisory LLC16,195$44K0.0%-20.0%0.004% 2/17/2026 Rice Hall James & Associates LLC1,425,088$3.89M0.2%-1.8%0.359% 2/17/2026 Gould Asset Management LLC CA31,735$87K0.0%+170.4%0.008% 2/16/2026 Squarepoint Ops LLC25,001$68K0.0%-42.9%0.006% 2/16/2026 WealthTrust Axiom LLC65,000$177K0.0%+62.5%0.016% 2/16/2026 MML Investors Services LLC111,848$305K0.0%N/A0.028% 2/16/2026 Healthcare of Ontario Pension Plan Trust Fund628,537$1.72M0.0%+379.8%0.158% 2/16/2026 Destination Wealth Management20,000$55K0.0%N/A0.005% 2/16/2026 Barclays PLC1,127,157$3.08M0.0%+20.3%0.284% 2/13/2026 Arete Wealth Advisors LLC18,700$51K0.0%-22.9%0.005% 2/13/2026 The Manufacturers Life Insurance Company 231,443$637K0.0%+2.8%0.058% 2/13/2026 Quinn Opportunity Partners LLC95,000$259K0.0%-40.6%0.024% 2/13/2026 CANADA LIFE ASSURANCE Co40,958$112K0.0%+20.4%0.010% 2/13/2026 Stifel Financial Corp329,815$900K0.0%-5.7%0.083% 2/13/2026 Rafferty Asset Management LLC706,450$1.93M0.0%+46.3%0.178% 2/13/2026 Headlands Technologies LLC70,662$193K0.0%N/A0.018% 2/13/2026 Charles Schwab Investment Management Inc.2,753,343$7.52M0.0%+9.9%0.694% 2/13/2026 State Street Corp20,161,445$55.04M0.0%+51.5%5.079% 2/13/2026 Dynamic Technology Lab Private Ltd16,872$46K0.0%N/A0.004% 2/13/2026 Caitong International Asset Management Co. Ltd33,737$92K0.3%+441.5%0.008% 2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC469,706$1.28M0.0%-2.5%0.118% 2/13/2026 Wells Fargo & Company MN1,993,337$5.44M0.0%+31.4%0.502% 2/13/2026 Rhenman & Partners Asset Management AB1,595,327$4.36M0.4%+45.3%0.402% 2/12/2026 HRT Financial LP4,356,010$11.89M0.0%+1,078.3%1.097% 2/12/2026 DRW Securities LLC28,558$78K0.0%N/A0.007% 2/12/2026 MetLife Investment Management LLC170,782$466K0.0%+20.5%0.043% 2/12/2026Cibc World Markets Corp20,344$56K0.0%N/A0.005% 2/12/2026 Renaissance Technologies LLC651,000$1.78M0.0%N/A0.164% Your book is inside (Ad)The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.Download your copy now.2/12/2026 Dimensional Fund Advisors LP1,539,110$4.20M0.0%-45.5%0.388% 2/12/2026 Federated Hermes Inc.9,551$26K0.0%-36.8%0.002% 2/12/2026 Granite Investment Partners LLC10,638$29K0.0%N/A0.003% 2/12/2026 Swiss National Bank606,456$1.66M0.0%+17.1%0.153% 2/12/2026 Nuveen LLC1,385,988$3.78M0.0%+10.7%0.349% 2/12/2026 Xponance LLC24,288$66K0.0%+19.4%0.006% 2/11/2026 Deutsche Bank AG690,416$1.89M0.0%+7.0%0.174% 2/11/2026 Motley Fool Asset Management LLC10,760$29K0.0%N/A0.003% 2/11/2026 Orion Investment Co1,856,934$5.07M1.6%+0.3%0.468% 2/11/2026 LPL Financial LLC623,072$1.70M0.0%+1.9%0.157% IOVA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IOVA shares? During the previous two years, 294 institutional investors and hedge funds held shares of Iovance Biotherapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($74.28M), Hood River Capital Management LLC ($66.54M), State Street Corp ($55.04M), Artisan Partners Limited Partnership ($33.61M), Invenomic Capital Management LP ($32.65M), Bank of America Corp DE ($29.80M), and Avoro Capital Advisors LLC ($25.90M).Learn more on Iovance Biotherapeutics' institutional investors. What percentage of Iovance Biotherapeutics' stock is owned by institutional investors? 77.03% of Iovance Biotherapeutics' stock is owned by institutional investors. Learn more on IOVA's institutional investor holdings. Which institutional investors have been buying Iovance Biotherapeutics' stock? Of the 257 institutional investors that purchased Iovance Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Invenomic Capital Management LP ($9.15M), Long Focus Capital Management LLC ($7.45M), State Street Corp ($7.43M), Perceptive Advisors LLC ($6.81M), Principal Financial Group Inc. ($4.57M), Palo Alto Investors LP ($4.36M), and HRT Financial LP ($3.99M). How much institutional buying is happening at Iovance Biotherapeutics? Institutional investors have bought a total of 53,418,232 shares in the last 24 months. This purchase volume represents approximately $132.78M in transactions. Which of Iovance Biotherapeutics' major shareholders have been selling company stock? Of the 65 institutional investors that sold Iovance Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bank of America Corp DE ($5.79M), Millennium Management LLC ($4.92M), Soleus Capital Management L.P. ($4.52M), Long Focus Capital Management LLC ($2.70M), Two Sigma Investments LP ($1.89M), Principal Financial Group Inc. ($1.59M), and Dimensional Fund Advisors LP ($1.39M). How much institutional selling is happening at Iovance Biotherapeutics? Institutional investors have sold a total of 32,622,202 shares in the last 24 months. This volume of shares sold represents approximately $78.26M in transactions. Related Companies TG Therapeutics Institutional Ownership Mirum Pharmaceuticals Institutional Ownership PTC Therapeutics Institutional Ownership Lantheus Institutional Ownership Terns Pharmaceuticals Institutional Ownership CG Oncology Institutional Ownership Belite Bio Institutional Ownership Rhythm Pharmaceuticals Institutional Ownership Immunovant Institutional Ownership Centessa Pharmaceuticals Institutional Ownership This page (NASDAQ:IOVA) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
